Innoviva (INVA) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 500.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500.44% |
| Dec 31, 2025 | -31.16% |
| Sep 30, 2025 | 7,312.78% |
| Jun 30, 2025 | 283.62% |
| Mar 31, 2025 | -227.56% |
| Dec 31, 2024 | -60.22% |
| Sep 30, 2024 | -98.52% |
| Jun 30, 2024 | -2,757.85% |
| Mar 31, 2024 | 4.76% |
| Dec 31, 2023 | 36.31% |
| Sep 30, 2023 | -64.23% |
| Jun 30, 2023 | -93.90% |
| Mar 31, 2023 | -7.91% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | 123.37% |
| Jun 30, 2022 | -80.70% |
| Mar 31, 2022 | -65.50% |
| Dec 31, 2021 | -108.06% |
| Sep 30, 2021 | 146.90% |
| Jun 30, 2021 | 12.89% |
| Mar 31, 2021 | 38.93% |
| Dec 31, 2020 | 29.65% |
| Sep 30, 2020 | -11.61% |
| Jun 30, 2020 | 113.23% |
| Mar 31, 2020 | 97.33% |
| Dec 31, 2019 | -78.51% |
| Sep 30, 2019 | -6.21% |
| Jun 30, 2019 | -18.64% |
| Mar 31, 2019 | 31.97% |
| Dec 31, 2018 | 788.35% |
| Sep 30, 2018 | 47.42% |
| Jun 30, 2018 | 57.56% |
| Mar 31, 2018 | 80.56% |
| Dec 31, 2017 | 22.04% |
| Sep 30, 2017 | 127.21% |
| Jun 30, 2017 | 179.02% |
| Mar 31, 2017 | 276.05% |
| Jun 30, 2014 | -24.44% |
| Mar 31, 2014 | -93.59% |
| Dec 31, 2013 | 5.60% |
| Sep 30, 2013 | -8.18% |
| Jun 30, 2013 | 6.01% |
| Mar 31, 2013 | -131.46% |
| Dec 31, 2012 | -17.47% |
| Sep 30, 2012 | -13.28% |
| Jun 30, 2012 | -48.21% |
| Mar 31, 2012 | 470.83% |
| Dec 31, 2011 | -90.37% |
| Sep 30, 2011 | -44.31% |
| Jun 30, 2011 | -20.37% |